This inventor holds 16 USPTO granted patents and 2 published patent applications, plus 3 CIPO patents and 2 EPO patents. Top assignees: Natreon, Inc., Indian Herbs Research & Supply Company, Ltd., Other. Active years: 2000-2019.
Location History:
- Benares, IN (2001 - 2003)
- Varanasi, IN (2000 - 2005)
- Calcutta, IN (2004 - 2014)
- Kolkata, IN (2015 - 2019)
Company Filing History:

Years Active: 2000-2019
Title: The Innovative Contributions of Shibnath Ghosal
Introduction
Shibnath Ghosal is a prominent inventor based in Calcutta, India. He has made significant contributions to the field of medicinal chemistry, particularly in the development of novel compounds for treating neurological disorders. With a total of 16 patents to his name, Ghosal's work has the potential to impact the treatment of conditions such as Alzheimer's disease.
Latest Patents
One of Ghosal's latest patents involves indolealkylamino-withasteroid conjugates and their method of use. This patent describes a group of indolealkylamino-withasteroid conjugates that have been isolated and purified. The synthetic method for creating these compounds is also provided. The patent demonstrates in vitro acetyl cholinesterase inhibitory activity, showcasing methods for treating dementia and dementia-related disorders, including Alzheimer's disease, as well as anxiety and depressive disorders in mammals.
Career Highlights
Throughout his career, Ghosal has worked with various companies, including Natreon, Inc. His experience in the industry has allowed him to develop and refine his innovative ideas, leading to the successful patenting of his inventions.
Collaborations
Ghosal has collaborated with notable individuals in his field, including Muruganandam Veeraragavan and Sanyasi Raju Kalidindi. These collaborations have likely contributed to the advancement of his research and the successful development of his patented compounds.
Conclusion
Shibnath Ghosal's contributions to medicinal chemistry and his innovative patents highlight his dedication to improving treatments for neurological disorders. His work continues to pave the way for advancements in the field, making a significant impact on healthcare.